These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 25377471)
1. Endothelin A receptor/β-arrestin signaling to the Wnt pathway renders ovarian cancer cells resistant to chemotherapy. Rosanò L; Cianfrocca R; Tocci P; Spinella F; Di Castro V; Caprara V; Semprucci E; Ferrandina G; Natali PG; Bagnato A Cancer Res; 2014 Dec; 74(24):7453-64. PubMed ID: 25377471 [TBL] [Abstract][Full Text] [Related]
2. β-arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced β-catenin signaling. Rosanò L; Cianfrocca R; Tocci P; Spinella F; Di Castro V; Spadaro F; Salvati E; Biroccio AM; Natali PG; Bagnato A Oncogene; 2013 Oct; 32(42):5066-77. PubMed ID: 23208497 [TBL] [Abstract][Full Text] [Related]
3. β-Arrestin 1 is required for endothelin-1-induced NF-κB activation in ovarian cancer cells. Cianfrocca R; Tocci P; Semprucci E; Spinella F; Di Castro V; Bagnato A; Rosanò L Life Sci; 2014 Nov; 118(2):179-84. PubMed ID: 24530737 [TBL] [Abstract][Full Text] [Related]
4. Blocking endothelin-1-receptor/β-catenin circuit sensitizes to chemotherapy in colorectal cancer. Cianfrocca R; Rosanò L; Tocci P; Sestito R; Caprara V; Di Castro V; De Maria R; Bagnato A Cell Death Differ; 2017 Oct; 24(10):1811-1820. PubMed ID: 28708138 [TBL] [Abstract][Full Text] [Related]
5. Endothelin A receptor drives invadopodia function and cell motility through the β-arrestin/PDZ-RhoGEF pathway in ovarian carcinoma. Semprucci E; Tocci P; Cianfrocca R; Sestito R; Caprara V; Veglione M; Castro VD; Spadaro F; Ferrandina G; Bagnato A; Rosanò L Oncogene; 2016 Jun; 35(26):3432-42. PubMed ID: 26522724 [TBL] [Abstract][Full Text] [Related]
6. Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression. Cianfrocca R; Tocci P; Rosanò L; Caprara V; Sestito R; Di Castro V; Bagnato A Oncotarget; 2016 Apr; 7(14):17790-804. PubMed ID: 26909598 [TBL] [Abstract][Full Text] [Related]
7. Macitentan blocks endothelin-1 receptor activation required for chemoresistant ovarian cancer cell plasticity and metastasis. Sestito R; Cianfrocca R; Rosanò L; Tocci P; Di Castro V; Caprara V; Bagnato A Life Sci; 2016 Aug; 159():43-48. PubMed ID: 26776834 [TBL] [Abstract][Full Text] [Related]
8. Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells. Rosanò L; Cianfrocca R; Spinella F; Di Castro V; Nicotra MR; Lucidi A; Ferrandina G; Natali PG; Bagnato A Clin Cancer Res; 2011 Apr; 17(8):2350-60. PubMed ID: 21220476 [TBL] [Abstract][Full Text] [Related]
9. miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma. Sestito R; Cianfrocca R; Rosanò L; Tocci P; Semprucci E; Di Castro V; Caprara V; Ferrandina G; Sacconi A; Blandino G; Bagnato A Oncotarget; 2016 Jan; 7(4):4009-23. PubMed ID: 26675258 [TBL] [Abstract][Full Text] [Related]
10. Endothelin-1/endothelin A receptor axis activates RhoA GTPase in epithelial ovarian cancer. Tocci P; Caprara V; Cianfrocca R; Sestito R; Di Castro V; Bagnato A; Rosanò L Life Sci; 2016 Aug; 159():49-54. PubMed ID: 26776837 [TBL] [Abstract][Full Text] [Related]
11. Endothelin-1/endothelin A receptor-mediated biased signaling is a new player in modulating human ovarian cancer cell tumorigenesis. Teoh JP; Park KM; Wang Y; Hu Q; Kim S; Wu G; Huang S; Maihle N; Kim IM Cell Signal; 2014 Dec; 26(12):2885-95. PubMed ID: 25194819 [TBL] [Abstract][Full Text] [Related]
12. Endothelin-1 axis fosters YAP-induced chemotherapy escape in ovarian cancer. Tocci P; Cianfrocca R; Sestito R; Rosanò L; Di Castro V; Blandino G; Bagnato A Cancer Lett; 2020 Nov; 492():84-95. PubMed ID: 32860850 [TBL] [Abstract][Full Text] [Related]